MacDonald, Thomas MHawkey, Chris JFord, IanMcMurray, John J VScheiman, James MHallas, JesperFindlay, EvelynGrobbee, Diederick EHobbs, F D RichardRalston, Stuart HReid, David MWalters, Matthew RWebster, JohnRuschitzka, FrankRitchie, Lewis DPerez-Gutthann, SusanaConnolly, EugeneGreenlaw, NicolaWilson, AdamWei, LiMackenzie, Isla S2017-04-192017-04-192017-06-14MacDonald, T M, Hawkey, C J, Ford, I, McMurray, J J V, Scheiman, J M, Hallas, J, Findlay, E, Grobbee, D E, Hobbs, F D R, Ralston, S H, Reid, D M, Walters, M R, Webster, J, Ruschitzka, F, Ritchie, L D, Perez-Gutthann, S, Connolly, E, Greenlaw, N, Wilson, A, Wei, L & Mackenzie, I S 2017, 'Randomized trial of switching from prescribed non-selective non-steroidal anti-inflammatory drugs to prescribed celecoxib : the Standard care vs. Celecoxib Outcome Trial (SCOT)', European Heart Journal, vol. 38, no. 23, pp. 1843-1850. https://doi.org/10.1093/eurheartj/ehw3870195-668Xhttp://hdl.handle.net/2164/8520Acknowledgements We would like to express our sincere gratitude to all the patients who participated in the study and all the doctors and nurses from each of the centres who contributed to the SCOT study. Recruiting Centres: Dundee: Wendy Saywood, Claudine Jennings, Alison McGinnis, Irene Donald, Emma Gellatly, Caroline Hall, Dawn Ross, Fiona Gowans, Kate Cowan, Wendy Urquhart, Patricia Robertson, Lesley Riley, Pamela Goodman, Moira Dryburgh, Johan McGill, Avril Donaldson. Aberdeen: Jacqueline Furnace, Joan Henderson, Frances Rentoul, Mandy Thompson, Emma Wilson, Heather Lawrence, Helen Keith, Julie Shotton. Edinburgh: Janet Thomson, Susan Begg, Julia Boyd, Theresa Harper, Guen Innes, Debra Kerr, Helen Reynolds, Lorraine Petrie, Janet Connelly, Morag McLean. Glasgow: Iain McInnes, Roger Sturrock, Linda Wilson, Geraldine Campbell, Rhona McKay, Kirsty Simpson, Joanne Flynn, Anne Benson, June Innes. Birmingham: Rachel Iles, Clare Taylor. Oxford: Ben Thompson, Sabrina Petersen, Pippa Whitbread, Marie-Lucie Gibbons, Mina Davoudianfar, Faye Alexander. Nottingham: Jen Dumbleton, Diane Stevenson, Vic Shepherd, David Goddard, Angela Andrew, Alice Cotton. Denmark: Michael Dall, Kasper Soltoft Larsen; Morten Rix Hansen, Viv Toft Lie, Ellen Kathrine Arve, Anita Hagelskaer, Susanne Leed Henriksen, Charlotte Enok Poulsen, Trine Ammentorp Gregersen, Birgith Kjaergaard, Dorthe Karup Holm, Brit Jorgensen, Anja Holmgaard, Vibeke Karlsen, Birgitte Vajsbaek. Amsterdam: Nils Visser, Helen van den Heuvel, Astrid Suiker, Nathalie Groetelaers, Aline Veurink-Westrik. Funding An unrestricted Investigator Initiated Research Grant from Pfizer USA to the University of Dundee. The University of Dundee was the legal sponsor of the study (responsible for all aspects of the trial). Some of the funding received from Pfizer USA went towards salaries for Dundee staff (TMM, IM AW, EF) and staff at other Universities. The University of Dundee disbursed study funding to all other investigator institutions so, for example, IF received research funding for the SCOT study indirectly from Pfizer (via the University of Dundee) as did other investigators. F.D.R.H. is partially supported by NIHR School for Primary Care Research, NIHR CLAHRC Oxford, NIHR Oxford BRC and Harris Manchester College, Oxford.9395932engNSAIDsCelecoxibCardiovascularArthritisR MedicineSupplementary DataRJournal article10.1093/eurheartj/ehw3873823